Impax Laboratories Inc (NASD:IPXL) is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It is one of the stocks in my portfolio. Their annual meeting is coming up on 5/12/2015. ProxyDemocracy.org had the votes of one fund when I checked and voted on 5/6/2015. I also […]
